Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

As a pharmaceutical wholesale dealer, how should we establish an effective compliance risk prevention system?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q410 · Category I: Renewals, changes and penalties for non-compliance (Q401–Q450)
Establishing an effective compliance risk-prevention system is fundamental to a pharmaceutical wholesaler's continued operation. First, appoint an independent compliance manager or team to oversee all business activities. Second, develop detailed written Standard Operating Procedures (SOPs) covering the entire process from procurement, receipt and storage to picking, packing and transport, and ensure all staff are trained accordingly. Third, establish a comprehensive record-keeping system so that the movement of every pharmaceutical product is clearly traceable. Fourth, conduct regular internal audits and risk assessments to identify and rectify potential compliance gaps proactively. Finally, work closely with professional consultants such as Rengangyongsheng (Hong Kong) Limited to obtain the latest regulatory updates and compliance guidance.

📘 Regulatory basis

The Department of Health’s Good Distribution Practice (GDP) for Wholesale Dealers in Pharmaceutical Products provides a detailed framework and requirements for establishing a compliant system.

📗 Drew Tang's recommendations

Do not treat compliance as a burden. Instead, view it as an opportunity to improve corporate management and core competitiveness. A robust compliance system can earn the trust of customers and regulatory authorities and safeguard long-term development.

📕 Risk notice

Neglecting to establish a compliance system may result in an unsatisfactory rating during a routine Department of Health inspection, even if no serious non-compliance has occurred, which could affect licence renewal. Remedial action after a problem arises will be much more costly.

Back to Category I: Renewals, Changes and Penalties for Breaches (Q401-Q450) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗